Home > News Shots > World

By Saradha | Aug 05, 2020 03:21 PM

Another US Company, which is the third one to develop vaccines, released study that indicates that its coronavirus vaccine candidate is safe and induces an immune response. Novavax, Inc released data pertaining to phase 1 trials on Tuesday. Two doses of the vaccine was administered to 131 volunteers. The results show that the participants developed a good response wherein they neutralized antibodies at levels more than four times higher than the average levels developed by people who had recovered from COVID-19. Neutralising antibodies fight the novel coronavirus in the body.

NovavaxInc released phase1trials vaccinedata showing promisingresults

"That's good. That's really encouraging," said Novavax president Dr. Gregory Glenn.

According to an analysis made from 15 randomly selected volunteers, the vaccine induced a response from T-cells, the report cited. 

Participants received two doses of the vaccine and they were administered both along with as well as without adjuvant, a component that boosts the immune system. 

Out of the 126 volunteers, five developed severe side effects such as muscle pain, nausea and join pain and one had a mild fever. The side effects reportedly lasted for two days or less. 

“Novavax also released animal data on Tuesday. In the study, 12 monkeys received two doses of the vaccine and were then exposed to the virus that causes Covid-19. Eleven of the 12 monkeys showed no signs of infection in their noses or lungs. One monkey, which received a low dose of the vaccine, briefly showed signs of infection in the lungs, but all signs of infection were gone two days later,” CNN reported.

Moderna and Pfizer are the two other companies which are developing vaccines and have released positive results from phase 1 data. Last week, both of those companies commenced their phase 3 trials with 30,000 volunteers.

, according to Moncef Slaoui, the head of the program, “Novavax, Moderna, Pfizer, Johnson & Johnson, AstraZeneca and GlaxoSmithKline have all received funding from the federal government's Operation Warp Speed Program to develop Covid-19 vaccines, and two more unnamed companies will also receive funding.”

He also added that he expects a vaccine to be available by December or January. He said he expects there would be enough vaccine available for every American by the end of 2021.

அரசியல், விளையாட்டு, நாட்டுநடப்பு, குற்ற சம்பவங்கள், வர்த்தகம், தொழில்நுட்பம், சினிமா, வாழ்க்கை முறை என பலதரப்பட்ட சுவாரஸ்யமான செய்திகளை தமிழில் படிக்க இங்கு கிளிக் செய்யவும்      



This page contains news relating to various facts and events. The views are generally about current affiars and general topics in diversified areas such as political, international, national, and regional issues, sports, health, travel, lifestyle, technology and business. People having similar interets on the above topics will find this page useful. NovavaxInc released phase1trials vaccinedata showing promisingresults | World News.